Autoimmune neuropsychiatric disorders manifesting with psychosis
Journal of Clinical Investigation · 15.10.2025 · 135 (20)
DOI: 10.1172/jci196507 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.10.2025. Verfasst von José Maria Cabrera-Maqueda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Hauptthemen laut MEDLINE: Psychotic Disorders, Autoimmune Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing recognition of a new category of encephalitides that occur in association with antibodies against neuronal surface proteins has prompted the use of terms like “autoimmune psychosis” and “autoimmune psychiatric disorders.” However, although psychosis and other psychiatric symptoms can occur in autoimmune encephalitides and systemic autoimmune diseases, evidence for a distinct psychiatric entity beyond these conditions is lacking. A particularly defining condition is anti-NMDA receptor encephalitis, which has been central to promoting concepts such as autoimmune psychosis and autoimmune psychiatric disorders. While anti-NMDA receptor encephalitis can resemble primary psychiatric conditions, certain clinical features often suggest the specific diagnosis. This Review traces the development of the autoimmune psychosis concept and examines the implications of framing it as a separate entity. We discuss leading theories of psychosis and the convergence of the NMDA receptor hypofunction/glutamate hypothesis with anti-NMDA receptor encephalitis mechanisms. The interest generated by such disorders has driven uncontrolled antibody testing in psychiatric populations, often neglecting pretest probability and favoring prevalence over diagnostic specificity. Finally, we highlight the main limitations of current approaches and propose directions for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- Service of Neurology, University Hospital Clínic of Barcelona, Barcelona, Spain.
- CaixaResearch Institute, Barcelona, Spain.
- Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Cabrera-Maqueda, J. M., Planagumà, J., Guasp, M., & Dalmau, J. (2025). Autoimmune neuropsychiatric disorders manifesting with psychosis. Journal of Clinical Investigation, 135(20). https://doi.org/10.1172/jci196507
Vancouver
Cabrera-Maqueda JM, Planagumà J, Guasp M, Dalmau J. Autoimmune neuropsychiatric disorders manifesting with psychosis. Journal of Clinical Investigation. 2025;135(20). doi:10.1172/jci196507
BibTeX
@article{CabreraMaqueda2025,
author = {Cabrera-Maqueda, José Maria and Planagumà, Jesús and Guasp, Mar and Dalmau, Josep},
title = {Autoimmune neuropsychiatric disorders manifesting with psychosis},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {20},
doi = {10.1172/jci196507}
}
EUVIMED